Transgene IL-21-Engineered T Cell-Based Vaccine Potently Converts CTL Exhaustion via the Activation of the mTORC1 Pathway in Chronic Infection

Journals Menu

Follow SCIRP

ISSN Print: 2160-5815
ISSN Online: 2160-5823
www.scirp.org/journal/wjv
E-mail: wjv@scirp.org

"Transgene IL-21-Engineered T Cell-Based Vaccine Potently Converts CTL Exhaustion via the Activation of the mTORC1 Pathway in Chronic Infection"
written by Aizhang Xu, Xueying Zhang, Rajni Chibbar, Andrew Freywald, Suresh Tikoo, Changyu Zheng, Jim Xiang,
published by World Journal of Vaccines, Vol.9 No.1, 2019

has been cited by the following article(s):

[1]	Directing T-cell immune responses for cancer vaccination and immunotherapy
	Vaccines, 2021

[2]	A T-cell epitope-based multi-epitope vaccine designed using human HLA specific T cell epitopes induces a near-sterile immunity against experimental visceral …
	Vaccines, 2021

[3]	Directing T-cell immune responses for cancer vaccination and immunotherapy. Vaccines 2021, 9, x
	2021

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

[1]	A T-Cell Epitope-Based Multi-Epitope Vaccine Designed Using Human HLA Specific T Cell Epitopes Induces a Near-Sterile Immunity against Experimental Visceral Leishmaniasis in Hamsters Vaccines, 2021 DOI:10.3390/vaccines9101058

[2]	Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy Vaccines, 2021 DOI:10.3390/vaccines9121392